RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer

with No hi ha comentaris
  • Llop-Guevara, A., Pellegrino, B., Pimentel, I., Villacampa, G., Solinas, C., Torres-Esquius, S., Campanini, N., Simonetti, S., Tommasi, C., Serra, O., Corianò, M., Boggiani, D., Michiara, M., Minari, R., Bortesi, B., Rapacchi, E., Dieci, M. V., Lambertini, M., Zoppoli, G., … Cruz, C. (2026). RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer. Npj Breast Cancer, 12(1), 58. https://doi.org/10.1038/s41523-026-00920-5

 

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *